We are passionate about improving patient healthcare through research, development and commercialization of pioneering molecular multiplex diagnostic solutions for a number of diseases, initially focusing on Respiratory Pathogens and Enteric Bacteria & Parasites.
Our lead product, Tandem-Plex (“T-Plex”), Multiplexed-tandem PCR is the unique patented technology allowing the detection of multiple targets in one sample without compromising analytical sensitivity and specificity. This helps in lowering healthcare costs and most importantly, improving patient outcomes. AusDiagnostics’ USA interdisciplinary team brings decades of experience and a proven track record in diverse fields including molecular immunology, informatics, clinical infectious diseases and in alitro diagnostics.
AusDiagnostics’ state-of-the-art manufacturing and R&D facilities are located in a high-tech park in Sydney, Australia. We are continuously working with our academic, clinical and commercial partners around the globe to push the boundaries of clinical sciences and translate our discoveries into products that improve the lives of patients worldwide.